Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.
The earnings figure itself is key, but a beat or miss on the bottom line can sometimes be just as, if not more, important. Therefore, investors should consider paying close attention to these earnings surprises, as a big beat can help a stock climb even higher.
2 Stocks to Add to Your Watchlist
The Zacks Earnings ESP, or Expected Surprise Prediction, aims to find earnings surprises by focusing on the most recent analyst revisions. The basic premise is that if an analyst reevaluates their earnings estimate ahead of an earnings release, it means they likely have new information that could possibly be more accurate. The core of the ESP model is comparing the Most Accurate Estimate to the Zacks Consensus Estimate, where the resulting percentage difference between the two equals the Expected Surprise Prediction.
The final step today is to look at a stock that meets our ESP qualifications. Exelixis (EXEL) earns a Zacks Rank #3 seven days from its next quarterly earnings release on May 10, 2022, and its Most Accurate Estimate comes in at $0.17 a share.
By taking the percentage difference between the $0.17 Most Accurate Estimate and the $0.14 Zacks Consensus Estimate, Exelixis has an Earnings ESP of 21.95%.
EXEL is just one of a large group of Medical stocks with a positive ESP figure. Idexx Laboratories (IDXX) is another qualifying stock you may want to consider.
Idexx Laboratories, which is readying to report earnings on May 4, 2022, sits at a Zacks Rank #4 (Sell) right now. It's Most Accurate Estimate is currently $2.27 a share, and IDXX is one day out from its next earnings report.
For Idexx Laboratories, the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of $2.25 is 0.81%.
EXEL and IDXX's positive ESP figures tell us that both stocks have a good chance at beating analyst expectations in their next earnings report.
Find Stocks to Buy or Sell Before They're Reported
Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Exelixis, Inc. (EXEL) : Free Stock Analysis Report
IDEXX Laboratories, Inc. (IDXX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research